Hepatitis B infection as a possible cause of focal segmental glomerulosclerosis (FSGS)

Clinical Nephrology

Volumn 65, Issue 5, 2006, Pages 381-384

  Herberth, J ^a   Herberth, Z ^b   Abul Ezz, S R ^b   Kumar, J ^b   Gokden, N ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; POTASSIUM; POTASSIUM CHLORIDE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; ELECTRON MICROSCOPY; FOCAL GLOMERULOSCLEROSIS; HEPATITIS B; HEPATITIS B VIRUS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; LABORATORY TEST; LETTER; LIVER BIOPSY; MALE; NEPHROTIC SYNDROME; PATIENT COMPLIANCE; PATIENT REFERRAL; PHYSICAL EXAMINATION; SEROLOGY; VIRUS REPLICATION; PATHOLOGY;

ADULT; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEPATITIS B; HUMANS; MALE; MICROSCOPY, ELECTRON; NEPHROTIC SYNDROME;

EID: 33646433039     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp65380     Document Type: Letter

References (23)

1. Abbas NA, Pitt MA, Green AT, Solomon LR. Successful treatment of hepatitis B virus (HBV)-associated membranoproliferative glomerulonephritis (MPGN) with alpha-interferon. Nephrol Dial Transplant. 1999; 14: 1272-1275.
2. Barisoni L, Kopp JB. Modulation of podocyte phenotype in collapsing glomerulopathies. Microsc Res Tech. 2002; 57: 254-262.
3. Connor FL, Rosenberg AR, Kennedy SE, Bohane TD. HBV associated nephrotic syndrome: resolution with oral lamivudine. Arch Dis Child. 2003; 88: 460.
4. Dettmeyer R, Wessling B, Madea B. Heroin associated nephropathy - a post-mortem study. Forensic Sci Int. 1998; 95: 109-116.
5. Dhiman RK, Kohli HS, Das G, Joshi K, Chawla Y, Sakhuja V. Remission of HBV-related mesangioproliferative glomerulonephritis after interferon therapy. Nephrol Dial Transplant. 1999; 14: 176-178.
6. Di Belgiojoso BG, Ferrario F, Landriani N. Virus-related glomerular diseases: histological and clinical aspects. J Nephrol. 2002; 15: 469-479.
7. Gonzalo A, Mampuso F, Barcelna R, Gallego N, Ortuno J. Membranous nephropathy associated with hepatitis B virus infection: long-term clinical and histological outcome. Nephrol Dial Transplant. 1999; 14: 416-418.
8. Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E. Cohen P; French Vasculitis Study Group. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine. 2005; 84: 313-322.
9. Halpern M, Citron BP. Necrotizing angiitis associated with drug abuse. Am J Roentgenol Radium Ther Nucl Med. 1971; 111: 663-671.
10. Lai KN, Lai FM, Lo ST, Lam CW. IgA nephropathy and membranous nephropathy associated with hepatitis B surface antigenemia. Hum Pathol. 1987; 18: 411-414.
11. Lai KN, Lai FM. Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults. Kidney Int. 1991; 40 (Suppl 35): 40-45.
12. Lai FM, Tam JS, Liew CT, Ip M, Lai KN. Low prevalence of hepatitis C virus antibodies with primary membranous nephropathy and membranoproliferative glomerulonephritis in Hong Kong. Nephron. 1995; 70: 367-368.
13. Lau GKK, Liang RHS, Wu PC, Lee CK, Lim WL, Au WY. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation. J Hepatol. 1998; 28: 359-368.
14. Lhotta A. Beyond hepatorenal syndrome: glomerulonephritis in patients with liver disease. Semin Nephrol. 2002; 22: 302-308.
15. Lin CY. Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int. 1995; 47: 225-230.
16. Nelson PJ, Geman IH, Klotman PE. Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes. J Am Soc Nephrol. 2001; 12: 2827-2831.
17. Oesterreicher C, Hammer J, Koch U, Pfeffel F, Sundre-Plassman G, Petermann D, Muller C. HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis. Kidney Int. 1995; 48: 1967-1971.
18. Sakkalioglu O, Gok F, Kalman S, Kurekci AE, Gunhan O, Gokcay E. Hepatitis B complicated focal segmental glomerulosclerosis. J Nephrol. 2005; 18: 433-435.
19. Stokes MB, Chawla H, Brady RI, Kumar A, Gertner R, Goldfarb DS, Gallo G. Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis. 1997; 29: 514-525.
20. Takaki A, Nakatsuka A, Satou C, Iwata Y, Ikeda H, Fukushima M. A case of focal segmental glomerulosclerosis (FSGS) complicated with chronic hepatitis B and treated with steroid and LDL apheresis. Nippon Jinzo Gakkai Shi. 2002; 44: 806-812.
21. Tang S, Lai FM, Lui YH, Tang CS, Kung NN, Ho YW, Chan KW, Leung JC, Lai KN. Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int. 2005; 68: 1750-1758.
22. Van den Berg JG, Weening JJ. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci (Lond). 2004; 107: 125-136.
23. Zong J, Zuo Y, Ma J, Fogo AB, Jolicoeur P, Ichikawa I, Matsusaka T. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int. 2005; 68: 1048-1060.